Obesity Trial, Recruiting NCT07293325 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07293325
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 75 years old
  • People diagnosed with obesity based on a BMI of 30 or higher
  • People who have not used any weight-loss medications (including GLP-1 drugs, tirzepatide, or metformin taken for weight loss) in the past 3 months
  • People who are able and willing to follow the study procedures and attend all required follow-up visits
  • People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People whose obesity is caused by an underlying medical condition, such as a hormone disorder like Cushing's syndrome or an underactive thyroid
  • People who have used weight-loss medications or taken part in another weight-loss program in the past 3 months
  • People diagnosed with type 1 or type 2 diabetes who are currently taking medication to lower their blood sugar
  • People with a history of pancreas inflammation, serious digestive system disease, or weight-loss surgery
  • People with serious heart, liver, kidney, or mental health conditions that could affect their ability to take part
  • Women who are pregnant, breastfeeding, or planning to become pregnant during the study
  • People currently taking part in any other clinical trial
  • People whom the trial doctors consider unsuitable for the study for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18857116176

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 June 2025
Est. completion
2 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in DNA methylation-based biological age measured by iWatchAge

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov